U.S. Other Utilities Stock News

What recent performance says about East West Bancorp East West Bancorp (EWBC) has drawn attention after a strong month, with the stock showing a 15% return and a gain of about 6% over the past 3 months. This recent performance has prompted some investors to reassess its valuation. See our latest analysis for East West Bancorp. Putting that move in context, the 15.0% 1 month share price return sits alongside a 3.5% year to date share price return and a 60.2% 1 year total shareholder return...

Setting the scene on Cboe Global Markets (CBOE) Cboe Global Markets (CBOE) has drawn fresh attention after the stock’s recent move, with investors weighing its current valuation against trading performance across options, equities, futures, and FX platforms. With a last close of $304.40 and a market cap of about $31.4b, Cboe’s recent returns over the past month and past 3 months are prompting closer scrutiny of how its diverse revenue streams support that pricing. See our latest analysis for...

Broadcom (AVGO) is back in focus after reports that Google may add Marvell as a custom AI chip partner, raising questions about how competition and supplier diversification could influence the stock’s recent strong run. See our latest analysis for Broadcom. The latest 1 day share price decline of 1.70% to US$399.63 comes after reports of Google talking to Marvell, but that pullback sits against a 30 day share price return of 28.70% and a very strong 1 year total shareholder return of 142.39%,...

Recently, Citigroup cut its rating on Insulet Corporation to Neutral, citing rising competition in the patch insulin pump market and the potential impact of rival devices expected to arrive in 2027. At the same time, Insulet appointed Mike Panos as Executive Vice President and Chief Commercial Officer, highlighting the company’s focus on strengthening global commercialization of its Omnipod platform despite a more crowded competitive landscape. Next, we’ll examine how Citigroup’s downgrade,...

Aehr Test Systems overview and recent performance context Aehr Test Systems (AEHR) has drawn attention after a sharp move in its share price, with the stock showing strong returns over the past month, past 3 months and year to date. For context, Aehr Test Systems focuses on designing, manufacturing and marketing advanced test and burn in products used across silicon carbide power devices, sensors, memory and other semiconductor applications. Its market value stands at about US$2.64b, with...

Royal Caribbean Cruises (RCL) has been back on investors’ radar after its stock rallied when Iran temporarily reopened the Strait of Hormuz, easing supply concerns, along with upbeat commentary on the company’s use of artificial intelligence. See our latest analysis for Royal Caribbean Cruises. Beyond the latest geopolitical and AI headlines, Royal Caribbean’s share price has had a mixed few months, with a 7.06% 1 month share price return and a 51.14% 1 year total shareholder return that...

In April 2026, Marsh & McLennan Companies reported first-quarter 2026 results showing sales of US$7,597 million, net income of US$1,146 million, and lower earnings per share year over year, alongside confirmation that it completed a US$1,074.65 million buyback covering 1.23% of shares since November 2025. While revenue increased compared with the prior year, the combination of declining net income and earnings per share with continued share repurchases highlights a shift in the balance...

Praxis Precision Medicines recently reported that the FDA accepted its New Drug Application for ulixacaltamide HCl to treat adult essential tremor, supported by statistically and clinically significant Phase 3 Essential3 data and prior Breakthrough Therapy Designation. This regulatory milestone, with a PDUFA action date set for January 29, 2027 and no planned advisory committee, could reshape expectations for Praxis’s central nervous system portfolio alongside its epilepsy programs. Next,...

Ingles Markets (IMKT.A) is in the middle of a high profile proxy fight after issuing open letters urging shareholders to back its nominees instead of activist-backed candidate Rory Held, as governance and conflict concerns take center stage. See our latest analysis for Ingles Markets. At a share price of US$88.11, Ingles Markets has seen a 25.10% 90 day share price return and a 26.47% year to date share price return. The 1 year total shareholder return of 39.65% contrasts with a 3 year total...

GRAIL (GRAL) stock is drawing attention after back to back announcements that extend access to its Galleri multi cancer early detection blood test through Epic’s electronic health record platform and Junction’s digital health infrastructure. See our latest analysis for GRAIL. Investors appear to be weighing these new distribution partnerships against a tougher recent trading history, with the share price at US$51.20, a 7 day share price return of 6.6% and a 90 day share price return showing a...

Cedar Grove Capital Management’s latest Q1 2026 investor letter put RealReal (REAL) in focus, pointing to its role in the fast growing second hand luxury market and recent operational and profitability metrics. See our latest analysis for RealReal. RealReal’s share price has been volatile, with a 36.9% 1 month share price return and a 25.1% decline year to date, while 1 year total shareholder return is 124.5%. If this kind of rebound catches your eye, it could be worth broadening your...

Earlier this month, Ultragenyx Pharmaceutical reported that the US FDA accepted its resubmitted Biologics License Application for UX111, an investigational AAV9 gene therapy for Sanfilippo syndrome Type A, and set a PDUFA action date of 19 September. If UX111 is ultimately approved, it could become the first available treatment for this rare, fatal pediatric neurodegenerative disorder, marking a potentially important expansion of Ultragenyx’s rare-disease gene therapy portfolio. We’ll now...

Index reshuffle puts Casey's in a new spotlight Casey's General Stores (CASY) has moved into a different investor bracket, leaving two Russell small cap composite indices and joining the S&P 500 Equal Weighted Index. This shift can change who owns the stock. This index change arrives as professional investors highlight Casey's for recent fuel margin and in-store sales performance. The development is drawing fresh attention to how the company is currently valued and where its returns are...

Conagra Brands (CAG) has announced a leadership transition. John Brase is set to become Chief Executive Officer and President on June 1, 2026, as Sean Connolly prepares to step down from both roles. See our latest analysis for Conagra Brands. Conagra Brands’ 7 day share price return of 2.27% sits alongside a 90 day share price return of a 13.57% decline and a 1 year total shareholder return of a 37.16% loss, suggesting momentum has been fading even as leadership and Mexico investment plans...

In April 2026, The Charles Schwab Corporation reported higher first-quarter net income of US$2,479 million and launched Schwab Crypto, offering direct bitcoin and ethereum trading alongside existing brokerage and advisory services. At the same time, Schwab continued capital management through share repurchases and introduced a new perpetual, non-cumulative preferred depositary share offering, slightly reshaping its funding and capital mix. We’ll now examine how the launch of Schwab Crypto,...

United States Antimony Corporation released a Technical Report Summary for its Fostung tungsten project in Ontario and restarted mining at its Stibnite Hill antimony property in Montana after a seasonal pause, resuming ore shipments through its integrated processing chain. The Fostung report highlights one of North America’s larger undeveloped tungsten resources with potential Defense Production Act support, underscoring how critical-mineral exposure and earlier-than-expected mine restart...

Acadia Realty Trust (AKR) has drawn attention after its recent share move, with the stock showing mixed short term performance in recent months and a comparatively stronger pattern over the past year. See our latest analysis for Acadia Realty Trust. At a latest share price of US$21.40, Acadia’s recent 10.37% 1 month share price return contrasts with a small 1 day pullback, while the 1 year total shareholder return of 14.57% and 3 year total shareholder return of 85.06% suggest momentum has...

Enact Holdings (ACT) has drawn investor attention after recent share price moves, with the stock closing at $43.13. That puts fresh focus on how its mortgage insurance business and current valuation line up. See our latest analysis for Enact Holdings. The recent 1 month share price return of 7.26% and 3 month return of 12.20% point to building momentum, while the 1 year total shareholder return of 27.59% and 3 year total shareholder return of 96.71% highlight how longer term holders have been...

What Russell Dicker’s Appointment Signals for Zoom Communications (ZM) Zoom Communications (ZM) has appointed Russell Dicker as chief product officer, tasking him with leading product strategy and AI integration across its collaboration platform. This leadership change could reshape how investors think about Zoom’s long term product direction. See our latest analysis for Zoom Communications. The Russell Dicker hire comes as momentum in Zoom’s stock has been building, with a 30 day share price...

Restaurant Brands International recently reported quarterly results showing revenue up 7.4% year on year, with both revenue and same-store sales surpassing analyst estimates. This earnings beat highlights how the company’s operational and sales momentum is tracking ahead of external expectations, potentially reinforcing confidence in its existing growth plans. We’ll now examine how this stronger-than-expected same-store sales performance may influence Restaurant Brands International’s...

DexCom, the San Diego-based continuous glucose monitoring company, released its fiscal first-quarter 2026 results on April 30, reporting diluted earnings of US$0.47 per share, which analysts had expected to be 46.9% higher than the same quarter a year earlier. This earnings release matters because it offers investors an updated read on how DexCom’s diabetes technology and reimbursement landscape are shaping current performance. We’ll now examine how DexCom’s first-quarter earnings update,...

Gogo Inc. ( NASDAQ:GOGO ), is not the largest company out there, but it received a lot of attention from a substantial...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Vir Biotechnology announced that its global collaboration and licensing agreement with Astellas has closed, bringing in a US$240,000,000 upfront payment, a US$75,000,000 equity investment at US$10.36 per share, and near-term and potential milestone payments tied to the development and commercialization of VIR-5500 for metastatic prostate cancer. At the same time, Vir has begun enrolling an expansion cohort in its Phase 1 trial of VIR-5500 following early safety and anti-tumor signals,...